Eye care market research

Euromonitor has the world’s most comprehensive research on the eye care category within the consumer health industry. We monitor and analyse industry trends around the world, including in-depth data on market share and market size – from the “big picture” qualitative analysis; down to specific category data.

Euromonitor data and market analysis cultivates your organization’s awareness of the eye care market and the greater competitive environment, ensuring accurate and focused strategies for your business.

A resource for your entire organization, Euromonitor market research supports every level of business, assisting in strategic development, marketing, mergers and acquisitions, and brand management.

Our eye care market research answer questions such as:

What is the market size of eye care?
What are the major brands in eye care?
How are population trends affecting eye care product sales?

Filter Results

Total: (80)

Country Report

Eye Care in Mexico

The ageing population is one of the forces driving demand for eye care products in Mexico, due to the dependence of this consumer group on prescription medication, which often has the side-effect of dry eyes. Other factors increasing the growth of ...

Feb 2013 | US$900| Add to cart | View details ›

Country Report

Eye Care in the United Arab Emirates

Eye care saw sluggish growth towards the end of the review period, with this linked to a lack of company investment in marketing or new product development. This is a largely mature niche, with low levels of consumer interest. The ongoing uptake of ...

Feb 2013 | US$900| Add to cart | View details ›

Country Report

Eye Care in Romania

Consumers are increasingly able to distinguish between various products and to buy some OTC products without prior medical consultation. This is particularly true of eye drops or ointments. An increasing number of people consider purchasing eye ...

Nov 2012 | US$900| Add to cart | View details ›

Country Report

Eye Care in Saudi Arabia

Eye care benefited from consumers spending longer in front of computer and TV screens during the review period, with this trend increasing the incidence of dry and itchy eyes. Many consumers notably worked longer hours on computers, as they sought to...

Nov 2012 | US$900| Add to cart | View details ›

Country Report

Eye Care in Egypt

Eye care is classified as Rx in Egypt and thus may only legally be sold with a prescription. Rx eye care is excluded from the scope of this report, while OTC eye care is thus insignificant.

Nov 2012 | US$900| Add to cart | View details ›

Country Report

Eye Care in Croatia

Eye care current retail value sales marginally decreased in 2011 – a performance which represents a recovery from 2010 when decline was 5%. Further market developments are expected to produce more positive figures over the forecasted period.

Oct 2012 | US$900| Add to cart | View details ›

Country Report

Eye Care in Slovenia

With the growth of tasks carried out on computers, the number of dry and tired eye problems saw a rising trend. Products in this category mostly target such problems. These products also target a wide group of potential customers; only children are ...

Oct 2012 | US$900| Add to cart | View details ›

Country Report

Eye Care in Kenya

Eye care is fairly nascent in Kenya. This can be attributed to the high cases of allergic reactions that form the basis of most eye diseases and infections. For many people, the use of spectacles is prohibiting and they opt for contact lenses, which ...

Sep 2012 | US$900| Add to cart | View details ›

Country Report

Eye Care in Pakistan

Growth of 19% in terms of value was seen in eye care in 2011. Long hours of work on computers and degradation of the environment combine to pose problems for the eyes, like dryness or redness. Medicines are consumed not only to combat these problems,...

Sep 2012 | US$900| Add to cart | View details ›

Country Report

Eye Care in Portugal

Current value sales of eye care in 2011 increased by 2% to reach €11 million. Standard eye care recorded the fastest current growth of 2%. The slow performance was relatively in line with that observed during the review period. Due to the slow ...

Sep 2012 | US$900| Add to cart | View details ›